TGFB1 and idiopathic pulmonary fibrosis: In contrast, the treatment of fibroblasts with ciprofibrate or WY14643, PPARα activators, led to peroxisome proliferation and reduced TGF-β–induced myofibroblast differentiation and collagen protein accumulation in IPF cells.